Alector (ALEC) Other Non-Current Liabilities (2018 - 2026)
Alector (ALEC) posted quarterly Other Non-Current Liabilities of $1.8 million for Q1 2026, up 26.97% year-over-year from $1.4 million in Q1 2025, and up 1.9% quarter-over-quarter from $1.7 million in Q4 2025.
Alector (ALEC) Other Non-Current Liabilities (2018 - 2026) Analysis & Trends
Alector (ALEC) has reported Other Non-Current Liabilities for 9 consecutive years, with $1.8 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Non-Current Liabilities rose 26.97% year-over-year to $1.8 million; the TTM figure through Mar 2026 stood at $1.8 million (up 26.97% YoY), while the FY2025 annual figure was $1.7 million, up 40.76% from the prior year.
- Other Non-Current Liabilities climbed to $1.8 million in Q1 2026 per ALEC's latest filing, from $1.7 million in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $1.8 million in Q1 2026 and bottomed at $158000.0 in Q1 2022.
- Historically, Other Non-Current Liabilities has averaged $1.1 million across 5 years, with a median of $1.2 million in 2024.
- Annual changes were most pronounced in 2023 — Other Non-Current Liabilities jumped 468.35% — and 2024, when it fell 10.12%.
- Alector's Other Non-Current Liabilities stood at $759000.0 in 2022, then jumped by 80.9% to $1.4 million in 2023, then dropped by 10.12% to $1.2 million in 2024, then surged by 40.76% to $1.7 million in 2025, then gained by 1.9% to $1.8 million in 2026.
- Business Quant data shows ALEC's Other Non-Current Liabilities at $1.8 million in Q1 2026, $1.7 million in Q4 2025, and $1.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Alector | 218.85 Mn | 46.05 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.02 Mn |
| Mar 31, 2026 | 1.77 Mn |
| Dec 31, 2025 | 1.74 Mn |
| Sep 30, 2025 | 1.44 Mn |
| Jun 30, 2025 | 1.44 Mn |
| Mar 31, 2025 | 1.39 Mn |
| Dec 31, 2024 | 1.23 Mn |
| Sep 30, 2024 | 1.23 Mn |
| Jun 30, 2024 | 1.23 Mn |
| Mar 31, 2024 | 1.37 Mn |
| Dec 31, 2023 | 1.37 Mn |
| Sep 30, 2023 | 898,000.00 |
| Jun 30, 2023 | 898,000.00 |
| Mar 31, 2023 | 898,000.00 |
| Dec 31, 2022 | 759,000.00 |
| Sep 30, 2022 | 233,000.00 |
| Jun 30, 2022 | 233,000.00 |
| Mar 31, 2022 | 158,000.00 |
| Dec 31, 2021 | 158,000.00 |
| Sep 30, 2021 | 158,000.00 |